Initial single-center experience of a standardized protocol for invasive assessment of ischemia and non-obstructive

Vera Vaz Ferreira1, Ruben Ramos1, Alexandra Castelo1

  • 1Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

Insights

A comprehensive coronary function test (CFT) is safe and feasible for diagnosing coronary vasomotion disorders (CVDs) like microvascular angina (MVA) and vasospastic angina (VSA) in patients with non-obstructive coronary artery disease (NOCAD). This test helps guide treatment for persistent angina.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Coronary vasomotion disorders (CVDs), encompassing microvascular angina (MVA) and vasospastic angina (VSA), contribute significantly to morbidity in patients with non-obstructive coronary artery disease (NOCAD).
  • Current clinical protocols for CVD assessment lack standardization and can be challenging to implement, leading to diagnostic delays and suboptimal patient management.

Purpose of the Study:

  • To evaluate the safety and feasibility of a comprehensive coronary function test (CFT) protocol for diagnosing CVDs.
  • To determine the prevalence of various CVD phenotypes in patients experiencing angina despite having non-obstructive coronary artery disease (ANOCA).

Main Methods:

  • Prospective recruitment of patients with persistent angina and NOCAD undergoing invasive coronary angiography.
  • Performance of a comprehensive coronary function test (CFT) including assessment of fractional flow reserve, coronary flow reserve, index of myocardial resistance, and coronary vasoreactivity.

Main Results:

  • The CFT was successfully and safely performed in all 20 participants (mean age 63±13 years, 50% female) without complications.
  • Prevalence of CVD phenotypes included isolated MVA (25%), isolated VSA (40%), mixed MVA and VSA (10%), and non-cardiac chest pain (25%).
  • CFT results led to antianginal therapy modification in 70% of patients.

Conclusions:

  • A comprehensive coronary function test (CFT) is a feasible and safe diagnostic tool for patients with angina and non-obstructive coronary artery disease (ANOCA).
  • CVDs are highly prevalent in this patient group, with a significant proportion exhibiting mixed phenotypes.
  • CFT enables definitive diagnosis and guides pharmacological therapy stratification for persistent angina.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
99
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
97
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
122